---
id: CTL-0009
type: control
title: EHDS electronic-health-data and EHR safeguard families
aliases:
  - EHDS secure processing controls
  - EHDS EHR interoperability and logging safeguards
status: active
created: 2026-07-12
updated: 2026-07-12
last_reviewed: 2026-07-12
review_after: 2026-10-10
source_ids:
  - SRC-0016
sensitivity: public
dual_use: low
control_status: binding-design-with-staged-application
implementation_status: unknown
testing_status: unknown
effectiveness_status: unknown
independent_evaluation_status: unknown
relations:
  - predicate: evidenced-by
    target: SRC-0016
    claim_id: CTL-0009-C01
    evidence:
      - source: SRC-0016
        locator: "Articles 3–16, 25–46, 53–75 and Annexes II–III, PDF pp. 34–55, 59–78, 93–95; Article 105, PDF pp. 90–91"
  - predicate: mitigates
    target: RSK-0004
    claim_id: CTL-0009-C02
    evidence:
      - source: SRC-0016
        locator: "Articles 53–54, 61, 66–75, PDF pp. 59–60, 64–78"
  - predicate: detects
    target: RSK-0004
    claim_id: CTL-0009-C02
    evidence:
      - source: SRC-0016
        locator: "Articles 9, 23, 59 and 73; Annex II §3, PDF pp. 36, 42–43, 63–64, 75–76, 93–94"
  - predicate: mitigates
    target: RSK-0005
    claim_id: CTL-0009-C03
    evidence:
      - source: SRC-0016
        locator: "Articles 53–54, 66–71 and 73, PDF pp. 59–60, 69–76"
  - predicate: mitigates
    target: RSK-0003
    claim_id: CTL-0009-C04
    evidence:
      - source: SRC-0016
        locator: "Articles 12–16, 25–46, 77–78 and Annexes II–III, PDF pp. 37–55, 78–79, 93–95"
  - predicate: governed-by
    target: GOV-0006
    claim_id: CTL-0009-C01
    evidence:
      - source: SRC-0016
        locator: "Regulation (EU) 2025/327, Articles 1–2 and 105, PDF pp. 29–33, 90–91"
tags:
  - european-union
  - electronic-health-data
  - ehr
  - access-control
  - logging
  - secure-processing
  - conformity
---

# EHDS electronic-health-data and EHR safeguard families

> Staged binding requirements under Regulation (EU) 2025/327. The page maps
> intended control relationships; it does not claim Member State deployment,
> product conformity, audit completion or field effectiveness.

## Applicability and staging

EHDS controls apply to different actors, objects and dates. Primary-use rights,
covered EHR-system requirements, secondary-use secure environments and future
implementing specifications must not be merged into one currently operational
baseline.

> **Claim record — CTL-0009-C01 | source-report**
> **Claim:** EHDS establishes staged binding safeguard families for patient/
> professional health-data access, covered EHR-system interoperability/logging
> and secondary-use permit/secure-environment processing, subject to distinct
> actor, object and Article 105 dates.
> **Claim status:** active
> **Scope:** Regulation (EU) 2025/327 design; not every healthcare system or
> current deployment.
> **As of:** 2026-07-12.
> **Review after:** 2026-10-10.
> **Evidence status:** single-source
> **Confidence:** high
> **Evidence:** [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md),
> Articles 3–16, 25–46 and 53–75, PDF pp. 34–55, 59–78; Annexes II–III,
> PDF pp. 93–95; Article 105, PDF pp. 90–91.
> **Basis / limits:** Families and staging are direct. Implementing acts,
> national law, product scope and operational results remain separate.

## Confidentiality and disclosure edges

For [RSK-0004](../risk-scenarios/rsk-0004-genomic-data-disclosure-kin-privacy.md),
EHDS conditionally addresses access/disclosure through purpose/permit limits,
named/unique users, secure environments, output review, access-event logging,
monitoring, audit and corrective action. It does not guarantee that data cannot
be linked or that privacy harm cannot occur after disclosure.

> **Claim record — CTL-0009-C02 | analytic-judgment**
> **Claim:** `CTL-0009` conditionally mitigates and detects the authorization/
> disclosure edges of `RSK-0004` through permit-bounded access, secure
> processing, output restriction, identity/logging, audit and correction;
> implementation and effectiveness are unknown.
> **Claim status:** active
> **Scope:** EU EHDS secondary-use and applicable primary/EHR access branches;
> not every disclosure scenario or a re-identification guarantee.
> **As of:** 2026-07-12.
> **Review after:** 2026-10-10.
> **Evidence status:** inferred
> **Confidence:** medium
> **Evidence:** [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md),
> Articles 9, 23, 53–54, 59, 61 and 66–75, PDF pp. 36, 42–43, 59–60,
> 63–78; Annex II §3, PDF pp. 93–94.
> **Basis / limits:** Intended functions are direct; exact scenario mapping is
> editorial. No control coverage, detection rate or disclosure outcome exists.

## Permitted-processing privacy edges

For [RSK-0005](../risk-scenarios/rsk-0005-permitted-genomic-processing-privacy-harm.md),
EHDS addresses purpose, minimisation, anonymised/pseudonymised access,
prohibited use, opt-out, public-interest exceptions, permit scope and result
disclosure. Legal permission remains distinct from technical authorization and
privacy acceptability.

> **Claim record — CTL-0009-C03 | analytic-judgment**
> **Claim:** `CTL-0009` conditionally mitigates the purpose-to-problem and
> privacy-problem edges of `RSK-0005` through permitted-purpose review,
> prohibited-use rules, minimisation, opt-out, permit constraints and secure
> processing, without implying that all permitted processing is harmless.
> **Claim status:** active
> **Scope:** EHDS-governed secondary use; no actual permit, dataset or person.
> **As of:** 2026-07-12.
> **Review after:** 2026-10-10.
> **Evidence status:** inferred
> **Confidence:** medium
> **Evidence:** [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md),
> Articles 53–54 and 66–73, PDF pp. 59–60, 69–76.
> **Basis / limits:** Regulatory interruption points are direct; effectiveness,
> national exceptions and residual privacy risk are unmeasured.

## Integrity, provenance and decision edges

For [RSK-0003](../risk-scenarios/rsk-0003-genomic-data-integrity-decision-harm.md),
health-professional identity, actor/time provenance, interoperability, EHR
logging, manufacturer documentation/validation, correction/market surveillance
and dataset quality/utility labels address selected input-to-decision and
quality-assurance edges. A label or declaration is not proof of correctness.

> **Claim record — CTL-0009-C04 | analytic-judgment**
> **Claim:** `CTL-0009` conditionally mitigates selected identity/provenance,
> exchange, EHR-system and dataset-quality edges of `RSK-0003`, while product
> declaration, required validation documentation and quality labels remain
> design/assurance evidence rather than demonstrated decision safety.
> **Claim status:** active
> **Scope:** EHDS-covered clinical/EHR and secondary-use branches, not every
> genomic analysis pipeline or downstream decision.
> **As of:** 2026-07-12.
> **Review after:** 2026-10-10.
> **Evidence status:** inferred
> **Confidence:** medium
> **Evidence:** [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md),
> Articles 12–16 and 25–46, PDF pp. 37–55; Articles 77–78, PDF pp. 78–79;
> Annexes II–III, PDF pp. 93–95.
> **Basis / limits:** Identity, provenance, conformity and label fields are
> direct; exact-edge mapping is inferred and no accuracy/effectiveness result
> is supplied.

## Control portfolio and assurance ladder

| Function | EHDS mechanism | Evidence maturity |
| --- | --- | --- |
| Prevent | purpose/permit limits, opt-outs, identity/access, secure environment, interoperability constraints | Staged binding design |
| Detect | EHR/access logs, monitoring, complaints, surveillance, audit | Required capability/process, no metric |
| Contain/respond | access restriction, correction, non-conformity action, withdrawal/recall, incident reporting | Required process, no exercised case |
| Recover/correct | rectification, corrective action and restoration of conforming state | No recovery-time or trustworthy-decision test |
| Assure | documentation, test-environment assessment, declaration, audit, quality label, public reports/evaluation | No completed independent effectiveness record |

> **Claim record — CTL-0009-C05 | analytic-judgment**
> **Claim:** Every represented EHDS safeguard remains at binding-design level;
> the Regulation's test, declaration, audit, report and evaluation requirements
> do not establish implementation, testing outcome, effectiveness or
> independent evaluation for a deployed control.
> **Claim status:** active
> **Scope:** Evidence ladder for this source transaction.
> **As of:** 2026-07-12.
> **Review after:** 2026-10-10.
> **Evidence status:** inferred
> **Confidence:** high
> **Evidence:** [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md),
> Articles 36–46, 59, 73 and 99–102, PDF pp. 50–55, 63–64, 75–76,
> 88–89; `SRC-0016-C08/C10`.
> **Basis / limits:** Required mechanisms are direct; no named deployment,
> completed audit, control comparison or outcome is in the source.

## Failure conditions and tradeoffs

- staged dates and missing/future implementing specifications constrain
  present operational conclusions;
- access rights and data availability remain bounded by patient safety, data
  minimisation, other Union/national law and purpose/permit conditions;
- interoperability or conformity claims can be misleading or non-conforming;
- anonymisation/pseudonymisation, secure environments and logs reduce selected
  risks but do not prove zero residual privacy risk;
- labels/documentation support accountability but can be incomplete or wrong;
- audit and market-surveillance powers require separate case evidence.

## Related pages

- [SRC-0016 — EHDS Regulation](../sources/src-0016-eu-ehds-regulation-2025.md)
- [GOV-0006 — EHDS governance](../governance/gov-0006-eu-ehds-regulation-2025.md)
- [SYN-0004 — US–EU governance comparison](../syntheses/syn-0004-us-eu-human-omics-health-data-governance.md)
- [RSK-0003 — Genomic integrity/decision path](../risk-scenarios/rsk-0003-genomic-data-integrity-decision-harm.md)
- [RSK-0004 — Genomic disclosure privacy path](../risk-scenarios/rsk-0004-genomic-data-disclosure-kin-privacy.md)
- [RSK-0005 — Permitted-processing privacy path](../risk-scenarios/rsk-0005-permitted-genomic-processing-privacy-harm.md)
- [CTL-0002 — Genomic risk management](ctl-0002-genomic-data-risk-management.md)
- [SYN-0006 — Official control function/state taxonomy](../syntheses/syn-0006-official-control-function-state-taxonomy.md)

## Sources

- [SRC-0016](../sources/src-0016-eu-ehds-regulation-2025.md), Articles and Annexes
  at the claim locators above.
